How Long Can You Take Gabapentin? Duration and Risks

Gabapentin has no preset maximum duration of use. Some people stay on it for years to manage epilepsy, neuropathic pain, or other chronic conditions, and early long-term data showed seizure control maintained for up to four years at stable doses without loss of effect. But “you can keep taking it” is different from “you should keep taking it indefinitely without reassessment.” The risks of gabapentin accumulate and shift over time, particularly for your bones, your brain, and your kidneys, and the calculus changes depending on your age, your other medications, and how well your kidneys are working.

There Is No Fixed Expiration Date on a Prescription

Gabapentin was originally approved for epilepsy and later for postherpetic neuralgia, the nerve pain that lingers after shingles. In clinical practice, it is prescribed for dozens of off-label uses including fibromyalgia, migraines, anxiety, and alcohol withdrawal. For epilepsy, the expectation is often lifelong use. For pain, prescribers sometimes treat it as a bridge medication, while other patients remain on it for years because it works and the alternatives are worse.

An early long-term observation of patients on stable gabapentin doses found that seizure improvement was maintained for up to four years with no sign of the drug losing its effectiveness, and doses up to 2,400 mg per day were well tolerated by most participants.¹ That study was small, but the broader clinical picture is similar: gabapentin does not appear to stop working the way some pain medications do. Tolerance to the pain-relieving or anticonvulsant effect is not a major documented problem, though tolerance to side effects like drowsiness often develops in the first weeks.

A separate open-label extension study in patients with postherpetic neuralgia tracked safety outcomes over a longer course and found that the most common side effects were mild, with a mean weight gain of less than one kilogram from baseline to the end of extended use.² That might make it sound reassuringly safe over time, but the real hazards of long-term gabapentin use are subtler and have become clearer only in recent years through large population-based studies.

Cognitive Decline and Dementia Risk

One of the most concerning findings from recent research is the relationship between cumulative gabapentin exposure and cognitive decline. A large study using Taiwan’s national health insurance database found a significant association between the total accumulated dose of gabapentin (and the related drug pregabalin) and the risk of developing dementia. People under 50 and those with higher cumulative doses appeared most vulnerable.³ This was an observational study, so it cannot prove gabapentin causes dementia, but the dose-response pattern (more drug exposure, higher risk) is the kind of signal researchers take seriously.

Separate work looking at older adults in the United States who had normal cognition at baseline found that starting gabapentin was associated with roughly 55 percent higher odds of worsening on a standard dementia rating scale at the next clinical visit, and nearly double the odds of worsening on a more sensitive functional measure at a later visit.⁴ The same study found that gabapentin use was tied to a roughly two-and-a-half-fold increase in fall risk at follow-up. Falls and cognitive slippage share a common thread: gabapentin dampens central nervous system activity, and with prolonged use, that dampening may be doing more than just controlling pain.

Fracture Risk Keeps Climbing

Falls are not just an inconvenience when you are on a medication that may also weaken your stability and bone health. A 2024 study published in JAMA Network Open found that gabapentinoid use was associated with roughly double the odds of hip fracture before adjusting for other factors, and even after accounting for other CNS medications the odds remained about 30 percent elevated. The risk was sharply higher in people with chronic kidney disease, where odds roughly doubled again.⁵

A nested case-control study in patients with inflammatory arthritis told a consistent story: current gabapentinoid use was linked to about 36 percent higher fracture odds, and the association was strongest in people who had started the medication recently.⁶ That finding is worth pausing on, because it means the risk is not just about years of accumulated exposure. Even people in the early months of use face elevated fracture risk, likely because gabapentin causes dizziness, sedation, and impaired coordination that can lead to falls before any chronic effects set in.

In hemodialysis patients, the picture is starker. Higher gabapentin doses were associated with a 38 percent increase in fracture risk and a 50 percent increase in altered mental status events.⁷ Even lower doses carried elevated risk of falls and confusion in that population.

Why Kidney Function Matters So Much

Gabapentin is not metabolized by the liver. It is excreted almost entirely through the kidneys, and its elimination is directly proportional to how well your kidneys filter blood.⁸ This means that as kidney function declines, gabapentin hangs around longer in the body at higher concentrations. In elderly nursing home patients, clearance depended heavily on estimated kidney filtration rate, not on age, weight, or sex.⁹

The clinical fallout from ignoring kidney function can be severe. A study of patients with chronic kidney disease found that gabapentin toxicity occurred in about 6 percent of those with moderate kidney impairment and in nearly 78 percent of those with severe impairment, and the toxic symptoms were more serious in the latter group. Clinicians initially suspected gabapentin as the cause in fewer than half the symptomatic cases, meaning the drug was often continued or increased while the patient was already accumulating toxic levels.¹⁰

For older adults with CKD, even the starting dose matters. A population-based cohort study found that initiating gabapentin at a higher dose, compared with a lower one, increased the 30-day risk of hospital visits for confusion, falls, fractures, or respiratory depression by about 27 percent.¹¹ The takeaway is practical: if you have any degree of kidney disease and your doctor wants to keep you on gabapentin long-term, the dose needs to be adjusted downward, and your kidney function should be monitored regularly.

The Opioid Interaction Problem

Gabapentin is frequently prescribed alongside opioids, sometimes specifically to reduce the opioid dose needed for pain control. But the combination carries a life-threatening interaction. A Canadian population-based study found that co-prescription of gabapentin with opioids was associated with roughly 49 percent higher odds of opioid-related death after adjusting for other factors, with moderate and high gabapentin doses both linked to about a 60 percent increase in risk.¹² The likely mechanism is twofold: the two drugs together suppress breathing more than either does alone, and opioids slow gut transit, which gives the upper small intestine more time to absorb gabapentin and raises its blood levels beyond what the dose alone would predict.

A systematic review and meta-analysis of the combination confirmed elevated risks for respiratory depression, dizziness, and cognitive problems in observational studies, with respiratory depression roughly 70 percent more common than with opioids alone.¹³ If you are on both drugs long-term, this risk is ongoing, not something that goes away once you adjust to the combination. Periodic reassessment of whether you still need both is essential.

Dependence and What Happens When You Stop

Gabapentin was long considered to have negligible abuse or dependence potential, which is one reason it was prescribed so freely as an opioid alternative. That reputation has eroded. A systematic review found clear evidence that gabapentin can produce tolerance, physical dependence, and withdrawal, which together warrant reevaluation of how casually it is prescribed.¹⁴ People with a history of substance use disorders or psychiatric conditions appear to be at particularly elevated risk for misuse.¹⁵

Withdrawal symptoms after stopping gabapentin can be surprisingly severe, even when the dose is tapered. A case report documented debilitating withdrawal, including anxiety, tremors, and flu-like symptoms, in a geriatric patient who was tapered over one week. The authors recommended that gabapentin tapers should follow a schedule more like a benzodiazepine taper: slowly, over weeks to months, not days.¹⁶ This matters for the duration question. Once you have been on gabapentin for months or longer, stopping is not a simple decision. You need a plan, and rushing the taper can itself be dangerous, particularly for people who use gabapentin for seizure control, where abrupt discontinuation can trigger rebound seizures.

Mood, Suicidality, and Behavioral Changes

All antiepileptic drugs carry an FDA-mandated warning about increased suicidal thoughts and behavior, and gabapentin is no exception. A case report detailed a patient who experienced marked personality changes, including increased depression, frustration, and aggression, after starting gabapentin.¹⁷ Case reports are the weakest form of evidence on their own, but a large population-based cohort study in Sweden provided a more nuanced picture. Using a within-individual design (comparing each person to themselves during periods on and off the drug), the study found that gabapentinoid treatment overall was associated with about a 26 percent increase in suicidal behavior and a 24 percent increase in unintentional overdoses. However, when the two gabapentinoids were examined separately, gabapentin alone was not significantly linked to increased suicidal behavior, while pregabalin was. The association was strongest in people aged 15 to 24.¹⁸

The practical implication: if you are younger or have any history of mood disorders, monitoring is important when starting gabapentin and should continue periodically throughout treatment. The risk may be more relevant for pregabalin, but the two drugs are similar enough that caution with either is reasonable.

Weight Gain and Swelling

Weight gain affects up to roughly a quarter of people taking gabapentin, likely driven by changes in appetite and gut function as well as fluid retention rather than a direct metabolic effect.¹⁹ Peripheral edema, the puffy swelling of the lower legs and ankles from fluid buildup, is a recognized side effect that can appear after months on a stable dose and may worsen with dose increases.²⁰ The edema sometimes resolves with dose reduction and sometimes requires stopping the drug. If you notice your shoes getting tighter or your ankles looking swollen, bring it up with your prescriber rather than assuming it is unrelated to the medication.

Cardiovascular Risk Over Five Years

A finding that gets less attention than it deserves: in patients with diabetic neuropathy, gabapentin use was associated with increased risk of several cardiovascular events over five years, including deep vein thrombosis (about 58 percent higher risk), pulmonary embolism (about 50 percent higher), peripheral vascular disease (about 37 percent higher), stroke (about 31 percent higher), heart attack (about 25 percent higher), and heart failure (about 14 percent higher).²¹ These are observational associations, and people prescribed gabapentin for diabetic neuropathy already have a disease that raises cardiovascular risk. But the hazard ratios persisted after adjusting for known cardiovascular risk factors, so the signal is worth knowing about if you are in this population and weighing whether to continue long-term.

Gabapentin During Pregnancy

For people of childbearing age on long-term gabapentin, pregnancy planning matters. A large US Medicaid cohort study found no clear increase in major birth defects overall with first-trimester gabapentin exposure, though there was a possible signal for heart defects. Use later in pregnancy was associated with higher rates of preterm birth, smaller-than-expected babies, and neonatal intensive care admissions.²² A subsequent cohort study with a meta-analysis found similar results: first-trimester exposure was not linked to increased malformation risk after adjustment, but gabapentin exposure during any trimester roughly doubled the likelihood of NICU admission.²³

A 2024 systematic review pooling animal and human data concluded that the combined evidence raises enough concern to warrant careful weighing of risks and benefits whenever gabapentin cannot be avoided during pregnancy, and noted links to preeclampsia as well.²⁴ If you are on gabapentin and considering pregnancy, the conversation about switching or tapering should happen before conception if possible, not after.

Older Adults Face Compounding Risks

Many of the risks described above converge in older adults: kidney function declines with age, polypharmacy is common, falls have more serious consequences, and cognitive reserve is lower. A retrospective study of over 110,000 older adults found that starting gabapentin at a high dose was associated with a 29 percent increase in the risk of being hospitalized for altered mental status within 30 days, and the risk was amplified in those with chronic kidney disease.²⁵ Many prescribers default to standard adult doses without adjusting for the slower clearance of an aging kidney, and the result is a drug that hangs around at higher concentrations than intended.

For older adults, the practical message is straightforward: if you have been on gabapentin for a long time, periodic reassessment should include checking kidney function, reviewing fall history, and asking specifically about memory or confusion. These conversations often do not happen unless the patient initiates them.

Drug Interactions Beyond Opioids

Gabapentin does not go through the liver’s main drug-processing enzymes the way most medications do, which means it has fewer traditional drug-drug interactions than you might expect. But it does interact with a handful of substances. Known interactions include morphine (which increases gabapentin absorption, as discussed above), certain blood pressure medications like losartan, the diuretic ethacrynic acid, the antimalarial mefloquine, the seizure medication phenytoin, and magnesium oxide, which can reduce gabapentin absorption if taken simultaneously. Even caffeine has been documented as interacting with gabapentin levels. The interaction with antacids containing aluminum or magnesium is well established and manageable: taking gabapentin at least two hours after antacids avoids most of the absorption problem.

Gabapentin for Alcohol Use Disorder

One increasingly common off-label use of gabapentin is for managing alcohol use disorder, particularly in people experiencing withdrawal symptoms. A randomized trial found that gabapentin-treated patients were about three times more likely to have no heavy drinking days and roughly four times more likely to achieve total abstinence compared to placebo, though these benefits were concentrated in participants who had more severe withdrawal symptoms before the study.²⁶ A large safety study of over 570,000 veterans found that the excess fall and fracture risk associated with gabapentin was observed in most patient subgroups but was not significantly elevated in those with alcohol use disorder, though that group already had high baseline rates of these events regardless of gabapentin exposure.²⁷

The duration question is particularly tricky here. Gabapentin may help with early sobriety and withdrawal, but maintaining someone on it indefinitely for alcohol relapse prevention means accepting all the long-term risks outlined above. Whether that tradeoff is worthwhile depends on how severe the alcohol problem is and what alternatives are available.

Pediatric Use Remains Poorly Studied

For parents wondering about long-term gabapentin use in children, the honest answer is that the evidence is thin. A systematic review of gabapentin and pregabalin for pain in children and adolescents found very little data to work with. Neither chronic pain study involving these drugs showed significant benefit over placebo or an older antidepressant. Two studies looking at short-term surgical pain found some benefit in reducing the need for other pain medications, but long-term safety data in pediatric populations is essentially absent.²⁸ If your child is on gabapentin for epilepsy, that is a different risk-benefit equation than pain management, but either way, periodic reassessment of whether the drug is still necessary and still working is more important in a population where we simply do not have long-term data.